Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

YIJIA GROUP CORP.

CIK: 16997092 Annual ReportsLatest: 2025-07-24

10-K / July 24, 2025

Revenue:$2,662,105
Income:$850,746

10-K / July 29, 2024

Revenue:$570,694
Income:$140,865

10-K / July 24, 2025

Yijia Group Corp. - Company Summary

Business Activities

  • Primary Business Operations:
    • Provides management consulting services focused on funding and financial advisory for domestic and international clients.
    • Markets and supplies healthcare products, particularly anti-aging products that increase NAD+ levels.
    • Offers personalized health consultation and develops customized nutrition and wellness plans based on individual customer conditions and goals.
    • Provides management, accounting, and financial advisory services to other businesses.

Revenue Streams

  • Consulting Service Segment:
    • Generates revenue through management, financial, and business consulting services.
    • Recognizes revenue over the period services are provided.
  • Healthcare Segment:
    • Primarily earns revenue from sale of healthcare products, including NAD+ boosting supplements (e.g., Nicotinamide Riboside capsules).
    • Recognizes revenue upon product delivery or customer pickup.

Financial Highlights (Year Ended April 30, 2025)

  • Total Revenue: $2,662,105
    • From healthcare product sales: $2,651,267
    • Consulting services: $10,838
  • Gross Profit: $1,575,710
  • Net Income: $850,746
  • Total Operating Expenses: $367,396
  • Income from Operations: $1,208,314

Customer and Market Data

  • Major customers are located in PRC (China), Hong Kong, and the USA.
  • During 2025, customers accounting for 10% or more of revenue include:
    • NOVA BIOLAB: $972,168 (37% of revenue)
    • Wansushe NG International: $1,072,230 (40% of revenue)
    • Tianjin Nuoan International Trade Co., Ltd: $374,880 (14% of revenue)

Employees

  • Number of Employees: 1 full-time employee (officers and staff are ready to expand as needed).

Recent Organizational Changes

  • The company was incorporated on January 25, 2017.
  • Changed name to Yijia Group Corp. on November 15, 2018.
  • Major shareholder Xianchang Ma acquired ~86.3% ownership in June 2023 but passed away in August 2023.
  • Control transferred to his heir, Ms. Caihong Qu.
  • Current management includes:
    • Qiuping Lu: CEO, President, and Director.
    • Ruiming Zhou: Director.
    • Dr. Steven Niu: CFO.

Subsidiary

  • Nutripeak Trading Corporation:
    • Founded on November 9, 2023.
    • Focused on marketing and supplying healthcare products.
    • Fully owned (100 shares).

Additional Notes

  • The company operates on a multi-channel marketing approach, including e-commerce, website, stores, social media, and direct sales.
  • The company has no research and development costs and currently does not maintain insurance.
  • Revenue growth was driven by increased sales of healthcare products, with a 366% increase from 2024 to 2025.
  • The company has a small number of stockholders (62 as of July 17, 2025).